Brightstar Capital Partners (“Brightstar”), a private equity firm focused on investing in business services, industrials, consumer, and government services and technology companies, announces that it has acquired Analyte Health (“Analyte” or the “Company”), a technology-driven, direct-to-consumer digital health company. Analyte Health provides discreet, high-quality diagnostic and treatment services across key consumer wellness categories. Powered by a proprietary technology stack and supported by a national network of partner laboratories and physicians, Analyte delivers an integrated experience spanning clinical testing, virtual care, and prescription fulfillment.
Read the full article: Brightstar Capital Partners Acquires Analyte Health, Establishing Platform in Direct-to-Consumer Healthcare //
Source: https://www.businesswire.com/news/home/20250804329578/en/Brightstar-Capital-Partners-Acquires-Analyte-Health-Establishing-Platform-in-Direct-to-Consumer-Healthcare